Felisa Gilbert, MD
Pediatrics · Smyrna, TNNPI 1295720605
Payments from drug & device makers
Across 216 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$779
- AbbVie$617
- Lilly USA, LLC$341
- AstraZeneca$170
- Amarin Pharma, Inc.$102
- Cranial Technologies, Inc$100
- plus $1K from 31 others
What the payments were for
- Food & beverage$3,502100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 49 | $779 |
| AbbVie(2 entities) | 39 | $617 |
| Lilly USA, LLC | 22 | $341 |
| AstraZeneca | 12 | $170 |
| Amarin Pharma, Inc. | 6 | $102 |
| Cranial Technologies, Inc | 8 | $100 |
| GSK | 6 | $98 |
| Bayer | 5 | $91 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $88 |
| Pfizer | 5 | $88 |
| Esperion Therapeutics, Inc. | 5 | $87 |
| Sanofi-aventis U.S. LLC | 6 | $87 |
| Astellas Pharma US Inc | 4 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $75 |
| Inspire Medical Systems, Inc. | 2 | $54 |
| Merck | 4 | $53 |
| Exact Sciences | 3 | $49 |
| Impel Pharmaceuticals LLC | 2 | $49 |
| Seqirus USA Inc | 3 | $46 |
| Boehringer Ingelheim | 3 | $44 |
| Novartis | 2 | $37 |
| Sanofi Pasteur Inc. | 2 | $36 |
| Dexcom, Inc. | 2 | $35 |
| Antares Pharma, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $30 |
| Ironshore Pharmaceuticals Inc. | 2 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Nevro Corp. | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| VBI Vaccine (delaware) Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Evoke Pharma, Inc. | 1 | $14 |
| Vistapharm, Inc. | 1 | $14 |
| Eisai Inc. | 1 | $12 |
How this compares
$3,502 in reported general payments places this provider in the 95th percentile of 1,338 pediatrics providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 31 | $31,025 |
| JardianceEmpagliflozin | 34 | $23,778 |
| JanuviaSitagliptin Phosphate | 16 | $12,828 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $11,997 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $4,544 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $2,898 |
| Ranolazine ErRanolazine | 11 | $1,565 |
| Atorvastatin Calcium | 146 | $1,444 |
| Levothyroxine Sodium | 155 | $1,250 |
| Rosuvastatin Calcium | 81 | $1,115 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $899 |
| Duloxetine Hcl | 30 | $875 |
| Pantoprazole Sodium | 52 | $744 |
| Losartan Potassium | 51 | $706 |
| Omeprazole | 53 | $701 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $341 | $31,02531 claims |
| Boehringer IngelheimJardiance | $44 | $23,77834 claims |
| MerckJanuvia | $53 | $12,82816 claims |
| GSKBreo Ellipta | $98 | $4,54411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,338 pediatrics providers in Tennessee.
Other pediatrics in Smyrna
- Clifford SeylerTullahoma$1.9M
- Nehali PatelMemphis$1.3M
- Richard GloverKnoxville$1.1M
- Joseph LeyKingsport$853K
- Laurie Harris-FordClarksville$401K
- Meghana SrinivasJohnson City$166K
- Madeline EllisGallatin$134K
- Jason JohnsonMemphis$131K
- Donald LewisKingsport$118K
- Daniel Moreira RidsdaleMemphis$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.